These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 2179176)
1. [Radiotherapy of head-neck neoplasms: prevention of inflammation of the mucosa by sucralfate treatment]. Scherlacher A; Beaufort-Spontin F HNO; 1990 Jan; 38(1):24-8. PubMed ID: 2179176 [TBL] [Abstract][Full Text] [Related]
2. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901. Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228 [TBL] [Abstract][Full Text] [Related]
4. Sucralfate in the prevention of radiation-induced oral mucositis. Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664 [TBL] [Abstract][Full Text] [Related]
5. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study. Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825 [TBL] [Abstract][Full Text] [Related]
6. Irradiation scheme using three daily fractions in the radiation therapy of pharyngeal and oral carcinomas. Durkovský J; Jancina J; Siracká E; Krajci M Neoplasma; 1984; 31(2):213-22. PubMed ID: 6717690 [TBL] [Abstract][Full Text] [Related]
7. [Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation]. Valls A; Pestchen I; Prats C; Pera J; Aragón G; Vidarte M; Algara M Med Clin (Barc); 1999 Nov; 113(18):681-4. PubMed ID: 10650568 [TBL] [Abstract][Full Text] [Related]
8. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3. Terhaard CH; Kal HB; Hordijk GJ Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903 [TBL] [Abstract][Full Text] [Related]
9. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study. Makkonen TA; Boström P; Vilja P; Joensuu H Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112 [TBL] [Abstract][Full Text] [Related]
10. [Z-100 as radiation mucositis protector in head and neck tumor management]. Miyashita T; Morita S; Shibuya H; Takeda M; Horiuchi J Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):295-7. PubMed ID: 8177707 [TBL] [Abstract][Full Text] [Related]
11. Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study. Sanguineti G; Franzone P; Marcenaro M; Foppiano F; Vitale V Strahlenther Onkol; 2003 Jul; 179(7):464-70. PubMed ID: 12835883 [TBL] [Abstract][Full Text] [Related]
12. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa. Gehrisch A; Dörr W Strahlenther Onkol; 2007 Jan; 183(1):36-42. PubMed ID: 17225944 [TBL] [Abstract][Full Text] [Related]
13. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169 [TBL] [Abstract][Full Text] [Related]
14. The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis. Barker G; Loftus L; Cuddy P; Barker B Oral Surg Oral Med Oral Pathol; 1991 Mar; 71(3):288-93. PubMed ID: 1707149 [TBL] [Abstract][Full Text] [Related]
15. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial. Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study. Makkonen TA; Minn H; Jekunen A; Vilja P; Tuominen J; Joensuu H Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):525-34. PubMed ID: 10701730 [TBL] [Abstract][Full Text] [Related]
17. [Can the prophylactic treatment of mycotic mucositis improve the time of performing radiotherapy in head and neck tumors?]. Gava A; Ferrarese F; Tonetto V; Coghetto F; Marazzato G; Zorat PL Radiol Med; 1996 Apr; 91(4):452-5. PubMed ID: 8643858 [TBL] [Abstract][Full Text] [Related]
18. Concomitant chemoradiotherapy for advanced head and neck cancer. Lin JC; Jan JS; Hsu CY Jpn J Clin Oncol; 1994 Apr; 24(2):94-100. PubMed ID: 8158863 [TBL] [Abstract][Full Text] [Related]
19. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors]. Altmann S; Hoffmanns H Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138 [TBL] [Abstract][Full Text] [Related]
20. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]